BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 23052993)

  • 21. Pharmacological Treatment of Opioid-Induced Constipation Is Effective but Choice of Endpoints Affects the Therapeutic Gain.
    Nusrat S; Syed T; Saleem R; Clifton S; Bielefeldt K
    Dig Dis Sci; 2019 Jan; 64(1):39-49. PubMed ID: 30284134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of constipation in palliative care patients is a challenge].
    Jarlbæk L; Johnsen B; Hansen OB; Hedal B
    Ugeskr Laeger; 2016 Aug; 178(33):. PubMed ID: 27550785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of constipation in palliative care patients.
    Clemens KE; Klaschik E
    Curr Opin Support Palliat Care; 2008 Mar; 2(1):22-7. PubMed ID: 18685390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paediatric palliative care: intravenous methylnaltrexone relieves constipation.
    Yeomanson D; Chohan O; Mayer A
    BMJ Support Palliat Care; 2013 Mar; 3(1):103-5. PubMed ID: 24644335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-analgesic effects of opioids: management of opioid-induced constipation by peripheral opioid receptor antagonists: prevention or withdrawal?
    Holzer P
    Curr Pharm Des; 2012; 18(37):6010-20. PubMed ID: 22747544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laxative Use in Inpatients on Oxycodone/Naloxone Prolonged Release and Oxycodone Prolonged Release for Cancer and Non-cancer Pain.
    Patel J; Lucas CJ; Margalit M; Martin JH
    J Pain Palliat Care Pharmacother; 2018; 32(2-3):116-123. PubMed ID: 30735070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Naloxegol: A Novel Therapy in the Management of Opioid-Induced Constipation.
    Jones R; Prommer E; Backstedt D
    Am J Hosp Palliat Care; 2016 Nov; 33(9):875-880. PubMed ID: 26150678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treating constipation in palliative care: the impact of other factors aside from opioids.
    Clark K; Byfieldt N; Dawe M; Currow DC
    Am J Hosp Palliat Care; 2012 Mar; 29(2):122-5. PubMed ID: 21606123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylnaltrexone: treatment for opioid-induced constipation.
    Licup N; Baumrucker SJ
    Am J Hosp Palliat Care; 2011 Feb; 28(1):59-61. PubMed ID: 20801917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Opioid-induced bowel dysfunction: a literature analysis on pathophysiology and treatment].
    Osterbrink J; Haas U
    Wien Med Wochenschr; 2008; 158(21-22):621-6. PubMed ID: 19052708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence about the pharmacological management of constipation, part 2: implications for palliative care.
    Pitlick M; Fritz D
    Home Healthc Nurse; 2013 Apr; 31(4):207-18. PubMed ID: 23549252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of Treatments for Opioid-Induced Constipation: Systematic Review and Meta-analysis.
    Nee J; Zakari M; Sugarman MA; Whelan J; Hirsch W; Sultan S; Ballou S; Iturrino J; Lembo A
    Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1569-1584.e2. PubMed ID: 29374616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylnaltrexone in palliative care: further research is needed.
    Clark K; Currow DC
    J Pain Symptom Manage; 2014 Feb; 47(2):e5-6. PubMed ID: 24411184
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy and side-effect profiles of lactulose, docusate sodium, and sennosides compared to PEG in opioid-induced constipation: a systematic review.
    Ruston T; Hunter K; Cummings G; Lazarescu A
    Can Oncol Nurs J; 2013; 23(4):236-46. PubMed ID: 24428006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and meta-analysis.
    Ford AC; Brenner DM; Schoenfeld PS
    Am J Gastroenterol; 2013 Oct; 108(10):1566-74; quiz 1575. PubMed ID: 23752879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. American Gastroenterological Association Institute Technical Review on the Medical Management of Opioid-Induced Constipation.
    Hanson B; Siddique SM; Scarlett Y; Sultan S;
    Gastroenterology; 2019 Jan; 156(1):229-253.e5. PubMed ID: 30337104
    [No Abstract]   [Full Text] [Related]  

  • 37. Efficacy of methylnaltrexone for the treatment of opiod-induced constipation: a meta-analysis and systematic review.
    Mehta N; O'Connell K; Giambrone GP; Baqai A; Diwan S
    Postgrad Med; 2016; 128(3):282-9. PubMed ID: 26839023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. European perspectives on pain and palliative care.
    Eisenberg E
    J Pain Palliat Care Pharmacother; 2009; 23(2):182-97. PubMed ID: 19492223
    [No Abstract]   [Full Text] [Related]  

  • 39. [Methylnaltrexone. A new approach for therapy of opioid-induced obstipation].
    Chappell D; Conzen P
    Schmerz; 2009 Oct; 23(5):471-8. PubMed ID: 19690895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of Opioid-Induced Constipation in Hospice Patients.
    Sera L; McPherson ML
    Am J Hosp Palliat Care; 2018 Feb; 35(2):330-335. PubMed ID: 28423917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.